70 related articles for article (PubMed ID: 35637651)
1. Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells.
Naguib A; Mathew G; Reczek CR; Watrud K; Ambrico A; Herzka T; Salas IC; Lee MF; El-Amine N; Zheng W; Di Francesco ME; Marszalek JR; Pappin DJ; Chandel NS; Trotman LC
Cell Rep; 2018 Apr; 23(1):58-67. PubMed ID: 29617673
[TBL] [Abstract][Full Text] [Related]
2. KLF4 transcription factor in tumorigenesis.
He Z; He J; Xie K
Cell Death Discov; 2023 Apr; 9(1):118. PubMed ID: 37031197
[TBL] [Abstract][Full Text] [Related]
3. Targeting oxidative stress with natural products: A novel strategy for esophageal cancer therapy.
Cao F; Zhang HL; Guo C; Xu XL; Yuan Q
World J Gastrointest Oncol; 2024 Feb; 16(2):287-299. PubMed ID: 38425393
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer.
Sirhan Z; Alojair R; Thyagarajan A; Sahu RP
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631304
[TBL] [Abstract][Full Text] [Related]
5. Deguelin Attenuates Non-Small-Cell Lung Cancer Cell Metastasis by Upregulating PTEN/KLF4/EMT Signaling Pathway.
Lu G; Yao Y; Zhang X; Cui D; Zhou J
Dis Markers; 2022; 2022():4090346. PubMed ID: 35637651
[TBL] [Abstract][Full Text] [Related]
6. Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway.
Li W; Yu X; Ma X; Xie L; Xia Z; Liu L; Yu X; Wang J; Zhou H; Zhou X; Yang Y; Liu H
Cell Signal; 2018 Oct; 50():131-141. PubMed ID: 30018008
[TBL] [Abstract][Full Text] [Related]
7. Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2.
Zhao D; Han W; Liu X; Cui D; Chen Y
Thorac Cancer; 2017 Jul; 8(4):320-327. PubMed ID: 28509438
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
9. SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4.
Li Z; Huang J; Shen S; Ding Z; Luo Q; Chen Z; Lu S
J Exp Clin Cancer Res; 2018 Dec; 37(1):323. PubMed ID: 30577808
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells.
Zhou H; Guan Q; Hou X; Liu L; Zhou L; Li W; Liu H
Int J Biol Sci; 2022; 18(13):4869-4883. PubMed ID: 35982899
[TBL] [Abstract][Full Text] [Related]
11. Advances in systemic therapy for non-small cell lung cancer.
Miller M; Hanna N
BMJ; 2021 Nov; 375():n2363. PubMed ID: 34753715
[TBL] [Abstract][Full Text] [Related]
12. ACY1 regulating PTEN/PI3K/AKT signaling in the promotion of non-small cell lung cancer progression.
Chen H; Wang W; Xiao C; Xia D; Li F; Liu S
Ann Transl Med; 2021 Sep; 9(17):1378. PubMed ID: 34733930
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in Pancreatic Cancer.
Feng L; Wang J; Zhang J; Diao J; He L; Fu C; Liao H; Xu X; Gao Y; Zhou C
Front Cell Dev Biol; 2021; 9():738709. PubMed ID: 34722520
[TBL] [Abstract][Full Text] [Related]
14. Conditional ERK3 overexpression cooperates with PTEN deletion to promote lung adenocarcinoma formation in mice.
Vallabhaneni S; Liu J; Morel M; Wang J; DeMayo FJ; Long W
Mol Oncol; 2022 Mar; 16(5):1184-1199. PubMed ID: 34719109
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
